Portal de Periódicos da CAPES

Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort

2022; Oxford University Press; Volume: 226; Issue: 11 Linguagem: Inglês

10.1093/infdis/jiac419

1537-6613

Ida Laake, Siri N. Skodvin, Kristine Blix, Ida Henriette Caspersen, Håkon K. Gjessing, Lene Kristine Juvet, Per Magnus, Siri Mjaaland, Anna Hayman Robertson, Jostein Starrfelt, Lill Trogstad, Berit Feiring,

Animal Virus Infections Studies

Understanding how booster vaccination can prevent moderate and severe illness without hospitalization is crucial to evaluate the full advantage of mRNA boosters.